We did not observe any association between plasma apoE levels and statin treatment, any of the known clinical comorbidities (CAD, CHF, hypertension, hyperlipidemia, cancer, diabetes, Afib, chronic renal failure, COPD, stroke/TIA), or scores on the area deprivation index, which is a better reflection of social economic status than household income as older people may have more assets than incomes. This evidence concerns the gene APOE and chronic obstructive pulmonary disease.